NHẬN XÉT HIỆU QUẢ SỬ DỤNG DUNG DỊCH MALTODEXTRIN 12,5% CHO NGƯỜI BỆNH TRƯỚC PHẪU THUẬT HÀM MẶT TẠI BỆNH VIỆN RĂNG HÀM MẶT TRUNG ƯƠNG HÀ NỘI NĂM 2024

Abstract

Objective: To investigate and evaluate the effectiveness of using 12.5% maltodextrin solution in patients undergoing maxillofacial surgery two hours prior to general anesthesia administration at the Hanoi National Hospital of Odonto-Stomatology. Subjects and Methods: A randomized clinical trial, without a control group was conducted on 44 patients undergoing maxillofacial surgery at the hospital from December 2023 to December 2024. Patients were given 200 ml of 12.5% maltodextrin solution two hours prior to surgery. Two hours before anesthesia, ultrasound was performed to assess gastric juice volume. Results: The mean gastric juice volume was 24.5 ± 23.6 mL. The gastric residual volume normalized to body weight was 0.4 ± 0.4 mL/kg. No cases of gastroesophageal regurgitation were recorded. 75% of patients reported no thirst preoperatively, significantly higher than the 47.7% reported postoperatively (p<0.05). Before surgery, 68% of patients reported no dry mouth, compared to 14% postoperatively (p<0.05). Conclusion: Oral administration of 200 ml of 12.5% maltodextrin solution two hours before general anesthesia is safe and effectively reduces preoperative thirst, dry mouth, and discomfort in patients undergoing maxillofacial surgery.